Pursuing appropriateness in antiphospholipid antibodies testing : Feasibility study with a reflex test approach for anti-β2GPI I domain
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Autoimmunity reviews - 22(2023), 11 vom: 21. Nov., Seite 103454 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Infantino, Maria [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 03.11.2023 Date Revised 16.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.autrev.2023.103454 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362380139 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362380139 | ||
| 003 | DE-627 | ||
| 005 | 20231226091122.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.autrev.2023.103454 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1207.xml |
| 035 | |a (DE-627)NLM362380139 | ||
| 035 | |a (NLM)37741530 | ||
| 035 | |a (PII)S1568-9972(23)00188-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Infantino, Maria |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pursuing appropriateness in antiphospholipid antibodies testing |b Feasibility study with a reflex test approach for anti-β2GPI I domain |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.11.2023 | ||
| 500 | |a Date Revised 16.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Anti-beta2-glycoprotein I IgG antibodies | |
| 650 | 4 | |a Antiphospholipid antibodies | |
| 650 | 4 | |a Antiphospholipid syndrome | |
| 650 | 4 | |a Thrombosis | |
| 650 | 4 | |a aβ2GPI-D1 | |
| 650 | 7 | |a beta 2-Glycoprotein I |2 NLM | |
| 650 | 7 | |a Antibodies, Antiphospholipid |2 NLM | |
| 650 | 7 | |a Antibodies, Anticardiolipin |2 NLM | |
| 700 | 1 | |a Foddai, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a Manfredi, Mariangela |e verfasserin |4 aut | |
| 700 | 1 | |a Benucci, Maurizio |e verfasserin |4 aut | |
| 700 | 1 | |a Radin, Massimo |e verfasserin |4 aut | |
| 700 | 1 | |a Cecchi, Irene |e verfasserin |4 aut | |
| 700 | 1 | |a Barinotti, Alice |e verfasserin |4 aut | |
| 700 | 1 | |a Aluf, Ofir |e verfasserin |4 aut | |
| 700 | 1 | |a Rubini, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Elnaz, Rahbari |e verfasserin |4 aut | |
| 700 | 1 | |a Menegatti, Elisa |e verfasserin |4 aut | |
| 700 | 1 | |a Roccatello, Dario |e verfasserin |4 aut | |
| 700 | 1 | |a Sciascia, Savino |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Autoimmunity reviews |d 2002 |g 22(2023), 11 vom: 21. Nov., Seite 103454 |w (DE-627)NLM126096996 |x 1873-0183 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2023 |g number:11 |g day:21 |g month:11 |g pages:103454 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.autrev.2023.103454 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2023 |e 11 |b 21 |c 11 |h 103454 | ||